000 | 01982 a2200613 4500 | ||
---|---|---|---|
005 | 20250515023306.0 | ||
264 | 0 | _c20060713 | |
008 | 200607s 0 0 eng d | ||
022 | _a0270-9139 | ||
024 | 7 |
_a10.1002/hep.21181 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFujii, Tsutomu | |
245 | 0 | 0 |
_aOverexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. _h[electronic resource] |
260 |
_bHepatology (Baltimore, Md.) _cJun 2006 |
||
300 |
_a1267-75 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLiver Neoplasms _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeovascularization, Pathologic _xgenetics |
650 | 0 | 4 | _aProbability |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 |
_aRNA, Neoplasm _xanalysis |
650 | 0 | 4 | _aReference Values |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aSampling Studies |
650 | 0 | 4 | _aSecurin |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTissue Culture Techniques |
700 | 1 | _aNomoto, Shuji | |
700 | 1 | _aKoshikawa, Katsumi | |
700 | 1 | _aYatabe, Yasushi | |
700 | 1 | _aTeshigawara, Osamu | |
700 | 1 | _aMori, Toshiaki | |
700 | 1 | _aInoue, Soichiro | |
700 | 1 | _aTakeda, Shin | |
700 | 1 | _aNakao, Akimasa | |
773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 43 _gno. 6 _gp. 1267-75 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.21181 _zAvailable from publisher's website |
999 |
_c16232655 _d16232655 |